Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 May;71(5):1074–1076. doi: 10.1038/bjc.1995.207

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors.

D W Miles 1, J Linehan 1, P Smith 1, I Filipe 1
PMCID: PMC2033804  PMID: 7734303

Abstract

Sialyl-Tn (STn) is a core region carcinoma-associated carbohydrate determinant expressed on cancer-associated mucins. Expression of STn has been associated with poor prognosis in colon and ovarian cancer, independent of other prognostic factors such as tumour grade, stage or histological type. Recent studies have suggested that STn expression may be an independent prognostic variable in gastric cancer. We have examined 158 patients with gastric cancer using the antibody B72.3 (Biomira, Edmonton, Alberta, Canada). Of these, 110 patients (70%) expressed STn. Expression of STn did not correlate with tumour differentiation or the Ming classification, but expression was noted more frequently in the relatively good prognosis intestinal type of tumours (chi 2 = 6.9, P = 0.03). Conversely, early-stage cancers showed a significantly lower frequency of expression than more advanced cases (chi 2 = 13.75, P = 0.003). In this patient group, STn expression did not influence survival, and in multivariate regression analysis only tumour stage and Lauren classification were found to be independent prognostic variables.

Full text

PDF
1074

Images in this article

1074Figure 1
on p.1074
1075Figure 2
on p.1075
1075Figure 3
on p.1075

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bresalier R. S., Niv Y., Byrd J. C., Duh Q. Y., Toribara N. W., Rockwell R. W., Dahiya R., Kim Y. S. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest. 1991 Mar;87(3):1037–1045. doi: 10.1172/JCI115063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. David L., Nesland J. M., Clausen H., Carneiro F., Sobrinho-Simões M. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl. 1992;27:162–172. [PubMed] [Google Scholar]
  3. Dennis J., Waller C., Timpl R., Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature. 1982 Nov 18;300(5889):274–276. doi: 10.1038/300274a0. [DOI] [PubMed] [Google Scholar]
  4. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985 Jun;45(6):2405–2414. [PubMed] [Google Scholar]
  5. Irimura T., Ota D. M., Cleary K. R. Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential. Cancer Res. 1987 Feb 1;47(3):881–889. [PubMed] [Google Scholar]
  6. Itzkowitz S. H., Bloom E. J., Kokal W. A., Modin G., Hakomori S., Kim Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer. 1990 Nov 1;66(9):1960–1966. doi: 10.1002/1097-0142(19901101)66:9<1960::aid-cncr2820660919>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  7. Kennedy B. J. T N M classification for stomach cancer. Cancer. 1970 Nov;26(5):971–983. doi: 10.1002/1097-0142(197011)26:5<971::aid-cncr2820260503>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 1988 Apr 15;48(8):2214–2220. [PubMed] [Google Scholar]
  9. Kobayashi H., Terao T., Kawashima Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol. 1992 Jan;10(1):95–101. doi: 10.1200/JCO.1992.10.1.95. [DOI] [PubMed] [Google Scholar]
  10. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  11. Ma X. C., Terata N., Kodama M., Jancic S., Hosokawa Y., Hattori T. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas. Eur J Cancer. 1993;29A(13):1820–1823. doi: 10.1016/0959-8049(93)90529-o. [DOI] [PubMed] [Google Scholar]
  12. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  13. Motoo Y., Kawakami H., Watanabe H., Satomura Y., Ohta H., Okai T., Makino H., Toya D., Sawabu N. Serum sialyl-Tn antigen levels in patients with digestive cancers. Oncology. 1991;48(4):321–326. doi: 10.1159/000226951. [DOI] [PubMed] [Google Scholar]
  14. Nakasaki H., Mitomi T., Noto T., Ogoshi K., Hanaue H., Tanaka Y., Makuuchi H., Clausen H., Hakomori S. Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers. Cancer Res. 1989 Jul 1;49(13):3662–3669. [PubMed] [Google Scholar]
  15. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Singhal A., Fohn M., Hakomori S. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res. 1991 Mar 1;51(5):1406–1411. [PubMed] [Google Scholar]
  17. Werther J. L., Rivera-MacMurray S., Bruckner H., Tatematsu M., Itzkowitz S. H. Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome. Br J Cancer. 1994 Mar;69(3):613–616. doi: 10.1038/bjc.1994.114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES